MAIN INDICATIONS:
It is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
DOSAGE AND USES:
Each unit-dose vials contain 500 mcg ipratropium bromide anhydrous in 2.0 ml normal saline. Ipratropium bromide inhalation solution can be mixed in the nebulizer with albuterol if used within one hour.
Contact